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Abstract
Background: Malaria presents a diagnostic challenge in tribal belt of central India where two
Plasmodium species, Plasmodium falciparum and Plasmodium vivax, are prevalent. In these areas, rapid
detection of the malaria parasites and early treatment of infection remain the most important goals
of disease management. Therefore, the usefulness of a new rapid diagnostic (RDT), the First
Response® Combo Malaria Ag (pLDH/HRP2) card test was assessed for differential diagnosis
between P. falciparum with other Plasmodium species in remote villages of Jabalpur district.
Methods: A finger prick blood sample was collected to prepare blood smear and for testing with
the RDT after taking informed consent. The figures for sensitivity, specificity, accuracy and
predictive values were calculated using microscopy as gold standard.
Results: Analysis revealed that overall, the RDT was 93% sensitive, 85% specific with a positive
predictive value (PPV) of 79%, and a negative predictive value (NPV) of 95%. The accuracy 88% and
J-index was 0.74. For P. falciparum, the sensitivity and specificity of the test were 96% and 95%
respectively, with a PPV of 85% and a NPV of 99%. The RDT accuracy 95% and J-index was 0.84.
For non-falciparum malaria, the sensitivity, specificity and accuracy were 83%, 94% and 92%
respectively with a PPV of 69% and a NPV of 97%.
Conclusion: The RDTs are easy to use, reliable and simple to interpret. RDTs are more suited to
health workers in situations where health services are deficient or absent. Therefore, the test can
be used as an epidemiological tool for the rapid screening of malaria.
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Background
Malaria is a major public health problem in tribal belt of
Central India where only two Plasmodium species, i.e.
Plasmodium falciparum and Plasmodium vivax are prevalent
[1,2]. The ethnic tribes that live in these areas often travel
several hours or days to reach the nearest Primary Health
Centre (PHC). In such areas laboratory facilities for diag-
nosis of malaria are often not available and the clinical
signs alone can not identify patients with malaria. Diag-
nosis of malaria made on the basis of clinical symptoms
is at best 50% accurate [3]. Further, PHC's clinics examin-
ing blood smears from a large number of clinically sus-
pected patients are often limited by one or two trained
microscopists resulting in misleading interpretation and
underestimation of malaria parasites. Consequently, a
considerable proportion of drugs have been wasted on
patients with non malarial disease due to lack of prompt
and accurate laboratory diagnosis. Presumptive treatment
of malaria encourages the development and spread of
drug resistant P. falciparum parasites [4]. Early diagnosis
and prompt treatment (EDPT) of malaria with efficient
drugs is required for effective malaria control.
Several rapid diagnostic test (RDTs) kits for malaria exist
for situations in which reliable microscopy may not be
available [5,6]. These tests are based on the detection of
antigens released from parasitized red blood cells [7]. In
the case of P. falciparum, these RDTs are based on detec-
tion of the P. falciparum histidine rich protein 2 (HRP2) or
of the Plasmodium specific lactate dehydrogenase
(pLDH). Species specific pLDH isoforms have been used
to develop a test for P. vivax [8]. Recently another rapid
test First Response® Combo Malaria Ag (pLDH/HRP2)
card test was developed in India for differential diagnosis
between P. falciparum and the other plasmodium species.
To determine the usefulness of new rapid test in low
endemic area where both P. falciparum and P. vivax are
prevalent, the diagnostic capacity of First Response®
Combo Malaria Ag (pLDH/HRP2) card test (Premier
Medical Corporation Ltd., Mumbai, India) was compared
with that of expert microscopy, the gold standard. Addi-




Jabalpur district in central India has a mixed rural, urban
and tribal population. This work was performed in Bargi
PHC located in forest in 25 km radius, from 21 August –
30 September 2007 during peak monsoon season. The
terrain of study area is highly undulating and inaccessible.
Villages are remote, thinly populated formed of six to 10
hamlets and located in field and forest. The inhabitants
are mainly ethnic Gond tribe (60% – 80%) and agricul-
ture is monsoon-dependant. Inhabitants are poor and live
in small, dark, mud plastered huts without electricity.
During the rains, perennial streams and its tributaries cre-
ates small water pool and remain as potential breeding
site for several months in which both the malaria vector,
Anopheles culicifacies and Anopheles fluviatilis breed pro-
fusely. Medical facilities are non-existent.
Sample collection
All fever cases in ten villages were screened for malaria
independently by microscopy and RDT to evaluate the
performance of the test under field conditions. Make-shift
field clinics were established in field where persons of all
ages visit for checkup, thus permitting performance of the
RDT in all persons suspected to have malaria, whatever
their history (recent malaria attack or with a history of
malaria in the previous 15 days), clinical status (high or
low grade fever, severe or mild symptoms) and other fac-
tors that may affect the sensitivity and the specificity of the
RDT. A questionnaire was filled for each patient with basic
clinical and demographic information after taking verbal
consent. The RDT kits were opened only after the patient
had been selected and interviewed by the medical staff.
Blood was obtained by finger prick for the First Response®
Combo Malaria Ag (pLDH/HRP2) card test and thick
smear before patients received treatment. In all 291 cases
were tested by the RDT after taking verbal consent.
RDT interpretation
The First Response ®Malaria pLDH/HRP2 Combo test con-
tains a membrane strip, which is pre-coated with two
monoclonal antibodies as two separate lines across a test
strip. One monoclonal antibody (test line 2) is pan-spe-
cific to lactate dehydrogenase (pLDH) of the Plasmodium
species (P. falciparum, vivax, malariae, ovale) and the other
line (test line 1) consists of a monoclonal antibody spe-
cific to histidine-rich protein 2 (HRP2) of the P. falciparum
species. The conjugate pad is dispensed with monoclonal
antibodies, which are pan-specific to pLDH and P. falci-
parum specific to HRP2. Blood sample was measured in a
calibrated dropper capable of delivering 5 μl sample accu-
rately into sample well followed by two drops of assay
buffer (60 μl) into developer well. Test card has one con-
trol line to indicate the validity of the test procedure and
it's working condition. Control and test lines appeared
within 20 minutes in a reading window. Thus, the RDT is
designed for the differential diagnosis between P. falci-
parum and other Plasmodium species. The interpretation of
the test is as described below:
Plasmodium falciparum positive reaction
The presence of three bands (control, test line 2 and test
line 1) or two bands (control and test line 1) indicates a
positive result for P. falciparum (or P. falciparum plus other
non-falciparum species).Malaria Journal 2008, 7:126 http://www.malariajournal.com/content/7/1/126
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Plasmodium vivax or other Plasmodium species positive reaction
The presence of two bands (control and test line 2) indi-
cates a positive result for non-falciparum malaria. The
pLDH present in the sample reacts with the pan anti-
pLDH conjugate and moves through the test strip where
the pLDH is captured by pan specific anti-pLDH.
Negative reaction
The presence of only one band in the control area indi-
cates a negative result. A one-hour workshop, including
training in blood collection from finger prick, perform-
ance and interpretation of RDT was conducted at National
Institute of Malaria Research Field Station Jabalpur
(NIMR) under the Indian Council of Medical Research
(ICMR) laboratory by one Medical Officer to two Field
Laboratory Assistants (FLAs). All specimens were tested
on site with the RDT by the FLAs as per manufacturer's
instructions. Simultaneously, thick blood smears were
also prepared.
Blood smears and microscopy
The blood smears were stained with JSB stain [9] and
examined on the same day by an experienced micro-
scopist in the laboratory of NIMR, without reference to
the results of the RDT/clinical status. Results of the RDT
and microscopy examination were recorded on separate
sheets. The microscopist examined 100 microscopic field
of thick smear before classifying a smear as negative. Par-
asite densities were calculated according to the standard
method (parasite/μl= no. of asexual parasites × 8,000/no.
of WBC counted) [10]. The result of both microscopy and
RDT were matched by an independent expert who was
blinded to the patient's clinical status, microscopy and
RDT results.
Treatment
All patients infected with P. falciparum and P. vivax were
given standard treatment as per National Vector-Borne
Disease Control Programme (NVBDCP). All adult sub-
jects with P. falciparum were administrated the standard
oral dose of chloroquine (1,500 mg chloroquine in three
days) followed by primaquine (45 mg as a single dose).
Non-falciparum cases were given 1,500 mg chloroquine
in three days, followed by 15 mg primaquine daily for five
days. Infants and children were given proportionally
lower doses. Infants were not given primaquine as per
National Vector Borne Disease Control Programme.
Quality control
If the results of the RDT testing conflicted with that of the
microscopy for any sample, the blood smear was re-exam-
ined by a different technician. This microscopist was also
blinded to the previous microscopy and RDT results. If
this re-examination gave a different result to the first
examination, the second result was confirmed by a third
examination by another technician.
Each RDT was saved as documentation for future refer-
ence. An independent staff re-read the saved tests after two
months and matched with that original interpretation of
results. The RDTs were stored properly (temperature 4 –
30°C) and used within shelf life. Only tests from one
batch were used (Manufacture June 07, expiry January 09
batch no. 61F0107).
Data analysis
The performance of RDT was expressed by calculating the
sensitivity, specificity, positive predictive values (PPV)
and negative predictive values (NPV) for P. falciparum and
non falciparum malaria separately taking microscopy
results as gold standard. The figures for specificity, sensi-
tivity, predictive values and efficiency were calculated as
suggested by Tjitra et al [11]. Data were double entered,
validated and analysed using Epi Info™ 3.3.2 software
(CDC Atlanta GA, USA). Proportions were compared
using the chi-square test. The study protocol was
approved by the ethics committee of the NIMR, Delhi.
Results
In all 291 patients (M:F, 1:1.15) with fever were suspected
of having malaria (age range < 1–60 years). The mean
duration of fever was four days (range 1 – 20 days) and
mean temperature was 100.5 ± 1.0 (range 98.6 – 103°F)
while in malaria infected persons mean temperature was
100.9 ± 1.1 (range 99 – 103°F). Out of 291, 113 (39%)
were found malaria infected, 41 with P. vivax (14%), 71
with P. falciparum which also include one mixed infection
(25%). Table 1 shows a breakdown of malaria cases in dif-
ferent age groups.
The results of parasite detection by microscopy and RDT
were compared in Table 2. Microscopically-confirmed P.
falciparum were 72, of which RDT detected 69 matching
positives. The asexual parasitaemias ranged from 80 -
111,920 parasites/μl (mean ± sd 8010.5 ± 21595.2). Only
three subjects were found as false negatives and 12 as false
positives. The sensitivity and specificity of the test for P.
falciparum was 96% and 95% respectively. The PPV and
NPV were 85% and 99% respectively. The accuracy was
95% and J index 0.84 (Table 3). Only two subject positive
for P. falciparum by microscopy with very low parasite
density (120 parasites/μl) were tested positive as non-fal-
ciparum malaria by RDT.
Out of 41 non-falciparum infections, RDT detected 34
matching positives, seven false negatives and 15 false pos-
itives. The asexual parasitaemias ranged from 200 –
14,800 parasites/μl (mean ± sd 1,871.58 ± 33,64.43). The
sensitivity of the test for non-falciparum malaria 83%Malaria Journal 2008, 7:126 http://www.malariajournal.com/content/7/1/126
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which was significantly lower when compared with P. fal-
ciparum  (≤ 0.05). However, specificity (94%), accuracy
(92%), PPV (69%) and NPV (97%) were not significantly
different from the corresponding values for P. falciparum.
Overall (pooled P. falciparum and non falciparum infec-
tions), the sensitivity and specificity were 93% and 85%
respectively with a PPV of 79% and a NPV of 95%. A com-
parison of parasitaemia versus RDT sensitivity showed
that with parasitaemia of ≥ 120 parasites/μl, RDT was
98% sensitive for P. falciparum. The only exception was
one subject with the parasite count of 840 parasites/μl
which was negative by RDT. For non-falciparum infec-
tions, the RDT did not identify seven subjects out of 41,
some of these, but not all had low parasitaemia (≤ 500
parasites/μl) and one subject with a parasite count of
4,480 parasites/μl.
The test was evaluated as very easy to perform, as the sam-
pling pipette made it very easy to measure exact 5 μl of
blood to be dispensed onto the sample well. The cassettes
were simpler to use and this is likely to affect test accuracy.
The results did not change after the 20 minutes. These
RDTs were reread after two months and the results
matched with that of original results.
Discussion
Several RDTs for malaria exist, which are fast, easy to per-
form and can be carried out by unskilled staff [7,12]. Of
these, two RDT, ParaHIT f  [13] and Paracheck-Pf [14]
based on the detection of parasite HRP2 have proven
superior to other tests [15,16]. Recently introduced First
Response RDT was evaluated for diagnostic capacity in
central India in an area of Jabalpur where malaria morbid-
ity is rising [17], especially P. falciparum due to labour
migration and other technical/administrative factors [14].
Results indicate that sensitivity for non falciparum
malaria infections in this study is markedly lower (83%;
CI, 69–91) than the corresponding values for P. falciparum
(96%; CI, 88–99), which is consistent with other stud-
ies[8,18,19]. It's known that anti-pLDH antibodies are
likely to be less temperature stable than HRP2 specific
antibodies and looses sensitivity more rapidly in uncon-
trolled storages[20]. Further, high humidity can rapidly
degrade pLDH based RDTs. This study was carried out
during main rainy season when humidity ranged between
80–100%. However, > 80% sensitivity recorded in this
study is relatively better than the ICT Pf/Pv RDT tested ear-
lier for non-falciparum infections (72% sensitivity) in
central India [6]. The NPVs were high for both P. falci-
parum and non-falciparum malaria. In field setting, a neg-
ative test corresponds in the vast majority of cases to a
non-infected individual.
However, from a clinical perspective, failure to diagnose
P. falciparum at 840 parasites/μl or non falciparum
malaria at 4,480 parasites/μl is a serious cause of concern.
This can be potentially dangerous, to miss the diagnosis of
malaria in a febrile patient which may develop complica-
tions in the absence of appropriate treatment. False nega-
tive RDT results in samples with higher parasitaemia have
Table 2: Diagnostic performance of First Response® Malaria Ag (pLDH/HRP2) card test Vs Light Microscopy as reference standard
Microscopy First Response® Malaria Ag (pLDH/HRP2) card test
Results N (%) Negative P. falciparum Non P. falciparum
Negative 178 (61.2) 153 12 13
P. falciparum 72 (24.7) 1 69 2
Non-P. falciparum 41 (14.1) 7 0 34
Table 1: Age group-wise prevalence of malaria among symptomatic patients (August – September 2007)
Age Groups (yrs) BSE* Positive P. vivax P. falciparum SPR† SfR‡ Pf%§
≤1 7 2 1 1 28.6 14.3 50.0
> 1 through 4 26 8 6 2 30.8 7.7 25.0
> 4 through 8 44 25 10 15 56.8 34.1 60.0
> 8 through 14 57 19 8 11 33.3 19.3 57.9
> 14 157 59 16 43 37.6 27.4 72.9
Total 291 113 41 72 38.8 24.7 63.7
* Blood Slide Examined
† Slide Positivity Rate (number of parasitaemic cases per 100 examined slides)
‡ Slide falciparum Rate (number of falciparum cases per 100 examined slides)
§Plasmodium falciparum percentage (number of falciparum cases per 100 parasitaemic cases)Malaria Journal 2008, 7:126 http://www.malariajournal.com/content/7/1/126
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been reported in earlier studies but the underlying reasons
are not known [19,21,22]. Polymorphisms in the Pf HRP2
protein may explain some of the variability in RDT per-
formance as extensive diversity was observed in Pf HRP2
sequences [23]. Further, the possibility of coincidental
rheumatoid factor causing false positive results can not be
excluded [24,25]. Among non-falciparum infections, P.
vivax is no longer considered a mild infection [26-28].
Analysis revealed a relatively large number of non falci-
parum infections false positive too. The reasons for the
false positivity of RDTs for non falciparum infections are
unknown. It is likely that some of the false-positive cases
were true positives which were not detected by micros-
copy due to very low parasitaemia. However, these are
unlikely to be applicable for the entire set of false positive
cases. It is probable that some of our patients with false
positive results may have taken self medication with anti-
malarial drugs during an attack of fever as prior self-med-
ication with antimalarials could not be completely
excluded. Thus in areas of low and moderate malaria
transmission, rapid tests require a high sensitivity at lower
densities of infection, to serve the non immune popula-
tions that can suffer from clinical disease at much lower
parasitaemia as opposed to people in high endemic areas
in Africa [29]. Clearly, more accurate results would be
expected if PCR had been used as the reference standard,
since PCR based methodology detect parasitaemia below
the limits of microscopy [18]. Further studies are required
to test this RDT in a group of patients with known/proven
arthritis, connective tissue disorder, tuberculosis,
typhoid/salmonella infection etc to confirm the extent of
cross reactivity.
The two microscopically detected P. falciparum case
shown as non-falciparum infections by RDT could have
been due to mixed infections with non-falciparum para-
sites. Further studies in various epidemiological settings
are required to establish accurately performance charac-
teristics of this new test.
In addition to performance of this RDT, some operational
observations were also made. The RDTs were re-read later
and recorded that results were not changed as recorded
earlier using MAKROmed RDTs in South Africa [30].
In remote and resource poor areas of central India micro-
scopy is not readily available and it can take -four to six
weeks before blood smear results are available as materi-
als, supply lines, trained staff are not sufficient. Addition-
ally, daily power cuts for- four to six hours is a major
problem. The delay in the diagnosis and treatment of
cases contributes to the continuing transmission. To con-
trol malaria, programme managers have to depend on
EDPT[31]. Given the logistic and financial difficulties of
microscopy in most field settings, only RDTs are viable
option at the present time in such areas.
However, despite its advantages over microscopy and clin-
ical diagnosis, the cost of this RDT is high $1.15 per test
(Nilesh Mehta, CEO & President PMC, Mumbai, personal
communication) and prevents its wide-spread use in
malaria endemic areas of developing countries where
many patients need a fever screen. Commercial interest in
producing RDTs at a cost that many of the tropical coun-
tries could afford is a subject of ongoing debate. However,
whatever the RDT costs, the cost-effectiveness of the accu-
rate diagnosis of malaria will become apparent as cheap
drug CQ may no longer be effective. Furthermore, RDTs in
cassette format tend to be simpler to use and this is likely
to affect test accuracy and may provide saving through
improved diagnosis.
In conclusion, the test is reliable and simple to interpret.
The test is a potential alternative to microscopy in places
where the facilities for microscopy are poor. Therefore, it
is reasonable to consider future use of RDTs as an epide-
miological tool for the rapid screening of malaria.
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